Recent searches
Search options
What M&A slowdown? Buyers circle GreenLight Biosciences, Egitis Therapeutics — Illumina urges shareholders to reject Carl Icahn’s board nominees as proxy fight heats up — Major readouts on the horizon for small developers -- See more on our front page news http://bit.ly/w28kSd #mergersandacquisitions #carlicahn #illumina #diagnostics #clinicaltrials #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
CafepharmaCafepharmaCafepharma is a site for the pharmaceutical/medical industry. Our scope includes pharmaceutical, device, biotech, laboratory, animal health, dental, etc. We have curated daily news headlines, active forums where users can post anonymously, job listings and more.